Healthcare Global Enterprises is currently trading at Rs. 261.75, up by 9.40 points or 3.72% from its previous closing of Rs. 252.35 on the BSE.
The scrip opened at Rs. 256.80 and has touched a high and low of Rs. 262.80 and Rs. 253.15 respectively. So far 1774 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 282.55 on 08-Nov-2021 and a 52 week low of Rs. 122.15 on 19-Nov-2020.
Last one week high and low of the scrip stood at Rs. 282.55 and Rs. 244.10 respectively. The current market cap of the company is Rs. 3164.89 crore.
The promoters holding in the company stood at 68.40%, while Institutions and Non-Institutions held 15.40% and 16.19% respectively.
HealthCare Global Enterprises (HCG) has acquired additional 60.9% stake in Suchirayu Healthcare Solutions (Suchirayu), Hubli, thereby becoming a majority stake owner from its existing 17.7% to 78.6%. Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds. HCG has operated and maintained the said entity’s hospital since August 2017 and had the right to increase its stake up to 80% in July 2022.
HCG also owns and operates a standalone Cancer Centre at Hubli, and the acquisition is expected to create synergetic benefits and market leadership in the geography. HCG and the current group of promoter doctors decided to bring HCG on board to collectively enhance the value moving forward. HCG has a successful track record of integrating acquisitions, and this acquisition will be in line with HCG’s strategy going forward.
HealthCare Global Enterprises (HCG) is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann’ brand.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 6694.40 |
| Max Healthcare Inst | 1039.35 |
| Narayana Hrudayalay | 1287.85 |
| Aster DM Healthcare | 489.85 |
| Global Health | 1023.35 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
